BioFactura
Phase 1BioFactura develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs..
Founded
2005
Focus
AntibodiesBiologicsBiosimilars
About
BioFactura develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs..
Funding History
4Total raised: $17.1M
Grant$149KBARDASep 15, 2021
Series B$10MNew Rhein Healthcare InvestorsJun 15, 2020
Series A$5.5MNew Rhein Healthcare InvestorsJun 15, 2017
Seed$1.5MMaryland Venture FundJun 15, 2015
Company Info
TypePrivate
Founded2005
LocationFrederick, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile